Bank of America
FHTX icon

Bank of America’s Foghorn Therapeutics FHTX Stock Holding History

Bank of America’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
26,103
-33,997
-57% -$151K ﹤0.01% 5497
2026
Q1 		$287K Sell
60,100
-13,759
-19% -$75.5K ﹤0.01% 5178
2025
Q4 		$399K Buy
73,859
+43,796
+146% +$199K ﹤0.01% 5034
2025
Q3 		$147K Sell
30,063
-1,234
-4% -$6.54K ﹤0.01% 6421
2025
Q2 		$147K Buy
31,297
+7,462
+31% +$31.2K ﹤0.01% 6327
2025
Q1 		$87K Sell
23,835
-7,827
-25% -$35.7K ﹤0.01% 6550
2024
Q4 		$149K Buy
31,662
+4,002
+14% +$29.2K ﹤0.01% 6236
2024
Q3 		$258K Buy
27,660
+753
+3% +$5.45K ﹤0.01% 5884
2024
Q2 		$155K Buy
26,907
+14,179
+111% +$84.5K ﹤0.01% 6029
2024
Q1 		$85.4K Sell
12,728
-16,345
-56% -$90.7K ﹤0.01% 6317
2023
Q4 		$188K Buy
29,073
+15,375
+112% +$66.3K ﹤0.01% 6102
2023
Q3 		$68.5K Buy
13,698
+6,175
+82% +$47.6K ﹤0.01% 6396
2023
Q2 		$53K Sell
7,523
-887
-11% -$6.2K ﹤0.01% 6444
2023
Q1 		$52.1K Sell
8,410
-5,779
-41% -$37.8K ﹤0.01% 6491
2022
Q4 		$90.5K Buy
14,189
+5,116
+56% +$38.6K ﹤0.01% 6266
2022
Q3 		$78K Sell
9,073
-2,163
-19% -$27.8K ﹤0.01% 6465
2022
Q2 		$153K Sell
11,236
-3,792
-25% -$48.9K ﹤0.01% 6265
2022
Q1 		$229K Sell
15,028
-4,985
-25% -$68.4K ﹤0.01% 6391
2021
Q4 		$458K Buy
20,013
+8,033
+67% +$115K ﹤0.01% 5951
2021
Q3 		$167K Sell
11,980
-290
-2% -$3.21K ﹤0.01% 6422
2021
Q2 		$131K Buy
12,270
+6,861
+127% +$74.8K ﹤0.01% 6357
2021
Q1 		$71K Buy
5,409
+3,755
+227% +$61.5K ﹤0.01% 6514
2020
Q4 		$34K Buy
+1,654
New +$31.7K ﹤0.01% 6455

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Bank of America's FHTX Position: Q2 2026 in Review

Bank of America reduced its Foghorn Therapeutics (FHTX) stake by 57% in Q2 2026, selling an estimated $151K and leaving 26,103 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #5497.

Bank of America first reported a position in FHTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $458K in Q4 2021. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Bank of America held 26,103 shares of Foghorn Therapeutics worth $127K as of Q2 2026.
  • Bank of America sold 33,997 Foghorn Therapeutics shares in Q2 2026, an estimated $151K.
  • Foghorn Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5497 holding.
  • Bank of America first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Bank of America's Foghorn Therapeutics position peaked at $458K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.